Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,365 | 433 | 98.7% |
| Education | $100.39 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,621 | 83 | $0 (2024) |
| Novo Nordisk Inc | $1,247 | 91 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $759.71 | 49 | $0 (2023) |
| ABBVIE INC. | $581.23 | 29 | $0 (2023) |
| Lilly USA, LLC | $480.08 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $423.36 | 22 | $0 (2024) |
| PFIZER INC. | $313.84 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $185.22 | 11 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $184.32 | 10 | $0 (2024) |
| Merck Sharp & Dohme LLC | $181.11 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $833.86 | 48 | AstraZeneca Pharmaceuticals LP ($217.46) |
| 2023 | $1,038 | 50 | AstraZeneca Pharmaceuticals LP ($191.73) |
| 2022 | $1,039 | 58 | AstraZeneca Pharmaceuticals LP ($242.91) |
| 2021 | $1,204 | 69 | AstraZeneca Pharmaceuticals LP ($255.87) |
| 2020 | $1,090 | 64 | AstraZeneca Pharmaceuticals LP ($241.59) |
| 2019 | $765.72 | 48 | AstraZeneca Pharmaceuticals LP ($230.11) |
| 2018 | $784.01 | 51 | AstraZeneca Pharmaceuticals LP ($194.90) |
| 2017 | $711.00 | 47 | Novo Nordisk Inc ($196.89) |
All Payment Transactions
435 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Becton, Dickinson and Company | BD MAX System, BD MAX Instrument (Device) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Diagnostic Testing | ||||||
| 12/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.09 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Obesity | ||||||
| 09/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Biological | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.34 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Obesity | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/02/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Obesity | ||||||
| 07/16/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Inflammation | ||||||
| 07/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: DIABETES | ||||||
| 06/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 364 | 458 | $64,065 | $24,958 |
| 2022 | 7 | 362 | 479 | $59,877 | $22,243 |
| 2021 | 9 | 452 | 579 | $76,800 | $27,258 |
| 2020 | 10 | 449 | 568 | $73,173 | $22,257 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 123 | $25,455 | $10,242 | 40.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 59 | $21,240 | $7,561 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $10,500 | $4,441 | 42.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 71 | 116 | $2,784 | $974.40 | 35.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 32 | 32 | $1,440 | $581.76 | 40.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $760.00 | $572.85 | 75.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 18 | 18 | $990.00 | $393.39 | 39.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 55 | 56 | $896.00 | $190.96 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 166 | $34,030 | $14,118 | 41.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 50 | 52 | $18,720 | $5,919 | 31.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 25 | $1,000 | $735.90 | 73.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 25 | 26 | $1,430 | $525.01 | 36.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 87 | 126 | $3,024 | $373.08 | 12.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $505.00 | $324.84 | 64.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 72 | 73 | $1,168 | $247.41 | 21.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 108 | 183 | $37,515 | $15,585 | 41.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 80 | 82 | $29,520 | $9,369 | 31.7% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 23 | 24 | $1,320 | $486.07 | 36.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 91 | 136 | $3,264 | $405.78 | 12.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 22 | 23 | $920.00 | $389.73 | 42.4% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2021 | 19 | 19 | $1,159 | $302.48 | 26.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 78 | 80 | $1,280 | $278.40 | 21.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 14 | 14 | $490.00 | $237.14 | 48.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 17 | 18 | $1,332 | $203.32 | 15.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 81 | 139 | $27,480 | $9,618 | 35.0% |
About Dr. Ralph Leon, MD
Dr. Ralph Leon, MD is a Family Medicine healthcare provider based in Sterling, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891789459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ralph Leon, MD has received a total of $7,465 in payments from pharmaceutical and medical device companies, with $833.86 received in 2024. These payments were reported across 435 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($7,365).
As a Medicare-enrolled provider, Leon has provided services to 1,627 Medicare beneficiaries, totaling 2,084 services with total Medicare billing of $96,716. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Sterling, VA
- Active Since 09/09/2005
- Last Updated 04/10/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1891789459
Products in Payments
- FARXIGA (Drug) $1,468
- Ozempic (Drug) $602.06
- SOLIQUA 100/33 (Biological) $429.68
- TRULICITY (Drug) $301.74
- UBRELVY (Drug) $231.62
- VRAYLAR (Drug) $218.80
- Victoza (Drug) $209.35
- JARDIANCE (Drug) $207.10
- TRADJENTA (Drug) $200.47
- JANUVIA (Drug) $154.46
- SOLIQUA (Drug) $152.38
- TRELEGY ELLIPTA (Drug) $143.85
- Wegovy (Drug) $138.12
- QULIPTA (Drug) $136.96
- MOUNJARO (Drug) $128.83
- Rybelsus (Drug) $111.14
- Saxenda (Drug) $108.60
- Vascepa (Drug) $105.76
- TRINTELLIX (Drug) $100.73
- DUEXIS (Drug) $95.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Sterling
Peter Toth, M.d, M.D
Family Medicine — Payments: $2.2M
Dr. Charles Gerk, M.d, M.D
Family Medicine — Payments: $37,719
Angel Blazquez, M.d, M.D
Family Medicine — Payments: $14,812
Svetlana Nakatis, M.d, M.D
Family Medicine — Payments: $7,951
Ricardo Ferreira Lopez, Md, MD
Family Medicine — Payments: $6,458
Phong Dang, M.d, M.D
Family Medicine — Payments: $4,674